Trailing-twelve-month (TTM) revenue is $2.20 Billion with a year-over-year growth of +2.53%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-26 | $510,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-29 |
| Q4 FY2025Period ended 2025-12-26 | $506,700,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-23 |
| Q1 FY2026Period ended 2026-03-27 | $533,700,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-29 |
| Q2 FY2026Period ended 2026-06-26 | $644,900,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-04 |
| TTM revenue | $2,195,300,000 |
Current P/S: $3,258,576,396 market capitalization ÷ $2,195,300,000 TTM revenue = 1.48x.
Market capitalization source: FMP quote. Quote observed 2026-10-02T20:00:00.000Z. Latest revenue period ended 2026-06-26.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-26): $644.90M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-03T03:54:50.943Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-02.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-26 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-26 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-25 · USD | FY20212021-12-31 · USD | FY20222022-12-30 · USD | FY20232023-12-29 · USD | FY20242024-12-27 · USD | FY20252025-12-26 · USD |
|---|---|---|---|---|---|---|
| Product | $1.1B | $1.8B | $2.1B | $1.5B | $1.9B | $1.8B |
| Service | $267M | $298M | $300M | $233M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-25 · USD | FY20212021-12-31 · USD | FY20222022-12-30 · USD | FY20232023-12-29 · USD | FY20242024-12-27 · USD | FY20252025-12-26 · USD |
|---|---|---|---|---|---|---|
| AUSTRIA | $57M | $99M | $117M | $125M | $178M | $222M |
| CHINA | $48M | $100M | $130M | $118M |
$2.20B
$2.20 Billion
+2.53%
vs. $2.14B a year ago (TTM)
+5.67%
5 Year compound annual growth rate
1 Year
+2.53%
3 Year
+2.21%
5 Year
+5.67%
10 Year
+16.70%
15 Year
+10.62%
20 Year
+13.72%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $2.05B | ($43.60M) | (2.08%) |
| 2024 | $2.10B | +$363.10M | +20.93% |
| 2023 | $1.73B | ($639.80M) | (26.95%) |
| 2022 | $2.37B | +$272.69M | +12.98% |
| 2021 | $2.10B | +$703.03M | +50.27% |
| 2020 |
TTM Growth
+2.53%
3-Year CAGR
+2.21%
5-Year CAGR
+5.67%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-03T03:54:50.943Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-02.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $244M |
| $255M |
| $143M |
| ILLINOIS | N/A | $22M | $19M | $18M | N/A | N/A |
|---|
| K R W | N/A | $153M | N/A | N/A | N/A | N/A |
|---|
| Korea (South), Won | N/A | N/A | $145M | N/A | N/A | N/A |
|---|
| KOREA, REPUBLIC OF | $84M | N/A | N/A | $94M | $103M | $113M |
|---|
| MALAYSIA | N/A | N/A | $47M | $22M | N/A | $78M |
|---|
| Other Geographical Areas | $34M | $127M | $171M | $151M | $241M | $191M |
|---|
| SINGAPORE | $494M | $779M | $736M | $609M | $712M | $754M |
|---|
| TAIWAN | N/A | N/A | $94M | $71M | $82M | $59M |
|---|
| TAIWAN, PROVINCE OF CHINA | $68M | $88M | N/A | N/A | N/A | N/A |
|---|
| UNITED STATES | $614M | $734M | $915M | $527M | $567M | $495M |
|---|
| $1.40B |
| +$332.38M |
| +31.17% |
| 2019 | $1.07B | ($30.32M) | (2.77%) |
| 2018 | $1.10B | +$172.17M | +18.63% |
| 2017 | $924.35M | +$361.59M | +64.25% |
| 2016 | $562.76M | +$93.66M | +19.96% |
